Journal article
Glycated Hemoglobin A1c Levels Are Not Affected by Critical Illness
N Luethi, L Cioccari, A Tanaka, P Kar, E Giersch, AM Deane, J Mårtensson, R Bellomo
Critical Care Medicine | Published : 2016
Abstract
Objectives: Glycated hemoglobin A1c is used to estimate glycemic control. However, its value upon ICU admission may be altered by critical illness and not reflect true glycemic status. We assessed the relationship between ICU admission glycated hemoglobin A1c and premorbid glycated hemoglobin A1c levels. Design: Retrospective observational cohort study. Setting: Two tertiary ICUs in Australia. Patients: Cohort of 69 critically ill patients with diabetes and glycated hemoglobin A1c levels measured upon ICU admission and during the month prior to admission. Interventions: Measurement of glycated hemoglobin A1c. Measurements and Main Results: Mean (sd) glycated hemoglobin A1c level was 7.5% (1...
View full abstractGrants
Funding Acknowledgements
Supported, in part, by the Austin Hospital Intensive Care Trust Fund. Dr. Kar received funding from The Royal Adelaide Hospital (AR Clarkson Scholarship-3-year scholarship which funds Dr. Kar's PhD research). Dr. Giersch's institution received funding from Diabetes Australia Research Trust Project Grant. Dr. Martensson's institution received funding from Austin Hospital Intensive Care Trust Fund. The remaining authors have disclosed that they do not have any potential conflicts of interest.